wound healing gel
DESCRIPTION
Wound Healing Gel. A Silver nanoparticle based hydrogel prepared by green synthesis. Novelty/Inventive component The product uses nanoparticle of silver formed by green synthesis Social Relevance Its an OTC product with vast market potential - PowerPoint PPT PresentationTRANSCRIPT
A Silver nanoparticle based hydrogel prepared by green synthesis
1
Wound Healing Gel
Novelty/Inventive component The product uses nanoparticle of silver formed by green synthesis Social Relevance Its an OTC product with vast market potentialUse of herbal product has better market acceptabilityHence very much required by the society
Commercial PotentialThe new product uses 0.02% silver nitrate while the traditional ones like Silverex® (Ranbaxy) uses 0.2% w/w. It’s a 10 times reduction in the quantity of silver used.
2
Proof of concept: Wound healing activity in Swiss Albino Wistar Rats.
0 7 14 210
20
40
60
80
100
Control Standard Formulation
Perc
enta
ge w
ound
hea
ling
Days
3
PROPOSAL AIMS AT
Aim: Seeking approval for further investigation regarding safety & stability of the product & conduct clinical trial
Key deliverables: •Evaluation of safety & stability of the product using analytical/bio-analytical method following ICH guidelines•Evaluation of microbial load in final product & identification of suitable preservative.•Conducting Phase – I clinical trial. 4
To establish safety, stability and efficacy through clinical trials
Work Plan
OBJECTIVES
Step 1 – Assessment of safety of the product: Skin irritation studies will be carried out using rabbits by Drazie test. The irritancy score shall be computed and based on response of skin.
Step 2 - Stability of the product: Effect of varying storage conditions on product stability/efficacy will be evaluated using suitable analytical/ bio-analytical method as per ICH guideline.
Step 3 – Evaluation and reduction of microbial load: Microbial load of the formulation will be assessed and attempt will be made to reduce the microbial load by incorporating preservative at optimum concentration.
Step 4 – Clinical trials: The safety/efficacy of the product will be proven through clinical trials.
5
ENVISAGED OUTCOME OF THE STUDY
The outcome of the project would be a comparatively cost effective formulation for treatment of wound healing that will be based on newer nanotechnology. The product will demonstrate adequate stability & safety.
After successful safety & stability test and DCGI approval, this project will go to Phase-2 for clinical trail study.
6
PRELIMINARY WORK UNDERTAKEN
7
Microbial efficacy by Agar Well diffusion Assay
Concentration
(µg/ml)Average zone of inhibition (mm)
E.coliAverage zone of inhibition (mm)
S.aureus
10 16 15
20 17 16
40 18 17
80 20 19
8
Characterization of nanoparticles: UV Spectroscopy
9
Crystallinity Studies: XRD
10
Electron microscopy (SEM)
11
Infrared Spectroscopy
12
Wound healing Activity : ays 7 & 14
13
Wound healing Activity: Days 14 & 21
14
Preparation of formulationSilver Nitrate
Addition of herbal extract
Formation of colloidal nanoparticles after heating
Addition of gelling polymer & preservative
Allow to stand overnight
Product 15
ENVISAGED OUTCOME OF THE STUDY
The outcome of the project would be a comparatively cost effective formulation for treatment of wound healing that will be based on newer nanotechnology. The product will demonstrate adequate stability & safety.
After successful safety & stability test and DCGI approval, this project will go to Phase-2 for clinical trail study.
16
List or marketed product Name of Product
Label drug content Manufacturer
Price & quantity
Silverex Ionic
0.2% Silver nitrate Ranbaxy Rs. 47 for 10g
BURNHEAL oint:
Silver sulphadiazine 1 % w/w, chlorhexidine 0.6 % w/w.
Cipla 15g per 20g
HYDROHEAL-AM topical gel:
Propylene glycol 4.96 % w/w, carbomer 0.76 % w/w, silver colloid 32 ppm, triethanolamine 0.32 % w/w.
Dr. Reddy’s
Rs. 69.5 for 15g
SILVINDON cream
1% w/w silver sulfadiazine Zydus (Indon)
Rs. 11.53 for 20g
ALOEDERM-B cream:
Aloe vera juice 30 % w/w, vitamin E acetate 0.5 % w/w, allantoin 0.5 % w/w, sodium pyrrolidone carboxylic acid 1 % w/w, silver sulfadiazine 1 % w/w, chlorhexidine gluconate 1 % w/w
Fem Care Rs. 33 for 15g
17
S.No. Limitation of Marketed products Advantage of Proposed Product
1 Silver sulphadiazine costs Rs. 13756 per 25 ghttp://www.sigmaaldrich.com/catalog/product/aldrich/481181?lang=en®ion=IN
Silver Nitrate costs Rs. 4143 per 25 ghttp://www.sigmaaldrich.com/catalog/search?interface=All&term=silver+nitrate&N=0&mode=match%20partialmax&focus=product&lang=en®ion=IN
2 Formulation containing silver nitrate in ionic form cause skin staining
Silver nanoparticle based product does not cause skin staining
3 Uses Silver sulphadiazine in 1%w/w or Silver nitrate 0.2%
Uses 10-3 M Silver nitrate which is 0.016987% w/w
RATIONALE
18
INFORMATION REGARDING IPR
Background IP details: Complete Patent Filled
IP owned by: Chandra, A., et al. c/o Amity University, Noida
Licensing details, if any: Nil
19
FUTURE PLANSThe success of the clinical trial would lead to the scale up,
process validation, large scale manufacture and finally commercialization and marketing of the product. This activity would be taken up in the next phase.
20
Thank You
21